Research Article

NF-κB-94ins/del ATTG Genotype Contributes to the Susceptibility and Imbalanced Th17 Cells in Patients with Immune Thrombocytopenia

Table 4

The results of NF-κB-94ins/del and clinical characteristics.

GenotypesAllelic frequency
WWWDDDAllele WAllele D

Gender
 Male62 (40%)56 (36.13%)37 (23.87%)180 (58.06%)130 (41.94%)
 Female117 (47.18%)90 (36.29%)41 (16.53%)324 (65.32%)172 (34.68%)
0.2820.0370.038
Stage
 nITP95 (46.8%)72 (35.47%)36 (17.73%)262 (64.53%)144 (35.47%)
 pITP27 (44.26%)20 (32.79%)14 (22.95%)74 (60.66%)48 (39.34%)
 cITP57 (41.91%)52 (38.24%)27 (19.85%)166 (61.03%)106 (38.97%)
 rITP02124
0.3960.3790.351
Severity
 sITP76 (42.94%)59 (33.33%)42 (23.73%)211 (59.60%)143 (40.40%)
 nsITP103 (45.58%)87 (38.50%)36 (15.93%)293 (64.82%)159 (35.18%)
0.3980.0610.129
Response
 CR + R149 (43.44%)122 (35.57%)72 (20.99%)420 (94.17%)26 (5.83%)
 NR30 (50.00%)24 (40.00%)6 (10.00%)84 (70.00%)36 (30.00%)
0.9380.0540.067
MAIPA
 Positive26 (37.68%)25 (36.23%)18 (26.09%)77 (55.80%)61 (44.20%)
 Negative37 (46.84%)23 (29.11%)19 (24.05%)97 (59.88%)65 (40.12%)
0.2570.4730.476